Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Comparative genomic hybridization produces a map of DNA sequence copy number as a function of chromosomal location throughout the entire genome. Differentially labeled test DNA and normal reference DNA are hybridized simultaneously to normal chromosome spreads. The hybridization is detected with two different fluorochromes. Regions of gain or loss of DNA sequences, such as deletions, duplications, or amplifications, are seen as changes in the ratio of the intensities of the two fluorochromes along the target chromosomes. Analysis of tumor cell lines and primary bladder tumors identified 16 different regions of amplification, many in loci not previously known to be amplified.

[1]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.

[2]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[3]  S. Dairkee,et al.  Immortalization in culture: occurrence at a late stage in the progression of breast cancer. , 1987, Journal of the National Cancer Institute.

[4]  P. Meltzer,et al.  Amplification units containing human N-myc and c-myc genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. D. Johnson,et al.  A simple method of reducing the fading of immunofluorescence during microscopy. , 1981, Journal of immunological methods.

[6]  J. Teyssier.  The chromosomal analysis of human solid tumors. A triple challenge. , 1989, Cancer genetics and cytogenetics.

[7]  M. Schwab,et al.  Oncogene amplification in tumor cells. , 1986, Advances in cancer research.